ArticleBMC gastroenterology2024

Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease.

Mira Thing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.